BenevolentAI

Company Snapshot

Founded: 2013
Entity Type: Public
Employees: 248
Region: U.K.
Revenue: $9.1 Millions
Revenue Year: 2023
Headquarter: U.K.
Key Geographics: U.K., European Union
Corporate Address: 9 rue de Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg U.K. Tel: +44-(0)20-3781-9360 Web: www.benevolent.com

Company Overview

BenevolentAI is a pioneering artificial intelligence company focused on accelerating the discovery and development of new medicines. BenevolentAI integrates advanced AI and machine learning techniques with scientific expertise to transform the way drugs are discovered and brought to market.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BenevolentAI In Reports

Artificial Intelligence (AI) in Pharmaceuticals: Global Markets

According to our research analyst the artificial intelligence ai in pharmaceutical market includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through...

AI in Biotechnology: Global Markets

Our detailed report on the AI in Biotechnology includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Artificial Intelligence (AI) in Life Sciences Market

BCC Research Market Analyst says global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023 & estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of...

Company's Business Segments

  • Drug Discovery : This segment offers an AI-enabled drug discovery platform and helps scientists successfully discover drugs.

Applications/End User Industries

  • Pharmaceutical Industry
  • Drug Discovery
AI Sentiment